Drug dispersion degree and drug dissolution rate in Hybrane S1200-based instant-release matricial particles prepared by hot melt extrusion

References

• Repka M, Battu K, Upadhye B, et al. Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm 2007;33:1043–57
   PubMed Web of Science ®Google Scholar
• Follonier N, Doelker E, Cole ET. Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained-release pellets prepared using polymeric materials. J Control Rel 1995;36:243–50
   Web of Science ®Google Scholar
• Rothen-Weinhold A, Oudry N, Schwach-Abdellaoui K, et al. Formation of peptide impurities in polyester matrices during implant manufacturing. Eur J Pharm Biopharm 2000;49:253–7
   PubMed Web of Science ®Google Scholar
• Crowley M, Schoroeder B, Fredersdorf A, et al. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm 2004;271:77–84
   PubMed Web of Science ®Google Scholar
• Prodduturi S, Manek V, Kolling M, et al. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci 2005;94:2232–45
   PubMed Web of Science ®Google Scholar
• Repka M, Gutta K, Prodduturi S, et al. Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur J Pharm Biopharm 2005;59:189–96
   PubMed Web of Science ®Google Scholar
• Ravina-Eirin E, Gómez-Amoza J, Martínez-Pacheco R. Utility of the hyperbranched polymer Hybrane S1200 for production of instant-release particles by hot-melt extrusion. Drug Dev Ind Pharm. 2013;39:1107–12
   PubMed Web of Science ®Google Scholar
• Thommes M, Ely D, Caravajal M, Pinal R. Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions. Mol Pharm 2011;8:727–35
   PubMed Web of Science ®Google Scholar
• Sarode A, Sandhu H, Shah N, et al. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug–polymer interactions on supersaturation. Eur J Pharm Sci 2013;48:371–84
   PubMed Web of Science ®Google Scholar
• Crowley M, Zhang F, Repka M, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909–26
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Boateng J, Chowdhry B, et al. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation. Drug Dev Ind Pharm 2014;40:145–56
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Rana M, Boateng J, et al. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Drug Dev Ind Pharm 2013;39:218–27
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Boateng J, Snowden M, Douroumis D. A review of hot-melt extrusion: process technology to pharmaceutical products. ISRN Pharm 2012;2012:436763, 9 pages
   Google Scholar
• Luo Y, Xu L, Xu M, et al. Improvement of dissolution and bioavailability of Ginsenosides by hot melt extrusion and cogrinding. Drug Dev Ind Pharm 2013;39:109–16
   PubMed Web of Science ®Google Scholar
• Feng J, Xu L, Gao R, et al. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 2012;38:735–43
   PubMed Web of Science ®Google Scholar
• Fu J, Xu L, Wang X, et al. Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 2011;37:934–44
   PubMed Web of Science ®Google Scholar
• Ranzani L, Font J, Galimany F, et al. Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion. Drug Dev Ind Pharm 2011;37:694–701
   PubMed Web of Science ®Google Scholar
• Yijie S, Meijuan Z, Yue A, et al. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Drug Dev Ind Pharm 2013;39:996–1004
   PubMed Web of Science ®Google Scholar
• Mallepally R. Enzymatic degradation of hyperbranched polyesters. J Appl Polym Sci 2009;112:1873–81
   Web of Science ®Google Scholar
• Suttiruengwong S, Roelker J, Smirnova I, et al. Hyperbranched polymers as drug carriers: microencapsulation and release kinetics. Pharm Dev Technol 2006;11:55–70
   PubMed Web of Science ®Google Scholar
• Seiler M. Hyperbranched polymers: phase behavior and new applications in the field of chemical engineering. Fluid Phase Equilib 2006;241:155–74
   Web of Science ®Google Scholar
• Yan D, Gao C, Frey H. Hyperbranched polymers: synthesis, properties and applications. Hoboken (NJ): John Wiley & Sons, Inc.; 2011
   Google Scholar
• Chen S, Zhang X, Cheng S, et al. Functionalized amphiphilic hyperbranched polymers for targeted drug delivery. Biomacromolecules 2008;9:2578–85
   PubMed Web of Science ®Google Scholar
• Inoue J, Shah T. Ophthalmic composition comprising a carbonic anhydrase inhibitor and a hyperbranched polymer. PCT Int Appl 2011;WO 2011140194 A1 20111110
   Google Scholar
• Yalkowsky S, Dannenfelser R. Aquasol database of aqueous solubility. 5th ed. Arizona: University of Arizona – Tucson; 1992
   Google Scholar
• HPLC Determinations Solutions Guide. Germany: Agilent Technologies (April 2000)
   Google Scholar
• Arwidsson H, Hjelstuen O, Ingason D, Graffner C. Properties of ethyl cellulose films for extended release. Part 2. Influence of plasticizer content and coalescence conditions when using aqueous dispersions. Acta Pharm Nord 1991;3:65–70
   Google Scholar
• Ricou P, Pinel E, Juhasz N. Temperature experiments for improved accuracy in the calculation of polyamide-11 crystallinity by X-ray diffraction. Int Centre Diffraction Data Adv X-ray Anal 2005;48:170–5
   Google Scholar